
Medicine and Health
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma
A. Nijhuis, A. Sikka, et al.
Discover how researchers Anke Nijhuis and colleagues have unleashed the potential of indisulam, a drug targeting RNA splicing factor RBM39, to combat high-risk neuroblastoma. Their groundbreaking study showcases complete tumor regression in xenograft models, reshaping our approach to pediatric cancer treatment.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.